WO2019045467A3 - 항산화 및 항고혈압 효과를 가지는 광어 연육 및 이의 제조방법 - Google Patents
항산화 및 항고혈압 효과를 가지는 광어 연육 및 이의 제조방법 Download PDFInfo
- Publication number
- WO2019045467A3 WO2019045467A3 PCT/KR2018/010028 KR2018010028W WO2019045467A3 WO 2019045467 A3 WO2019045467 A3 WO 2019045467A3 KR 2018010028 W KR2018010028 W KR 2018010028W WO 2019045467 A3 WO2019045467 A3 WO 2019045467A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- flatfish
- paste
- hydrolysates
- fractions
- peptides isolated
- Prior art date
Links
- 241000269978 Pleuronectiformes Species 0.000 title abstract 8
- 230000003078 antioxidant effect Effects 0.000 title abstract 2
- 230000003276 anti-hypertensive effect Effects 0.000 title 1
- 239000003963 antioxidant agent Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 abstract 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 230000002292 Radical scavenging effect Effects 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 230000030833 cell death Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003859 lipid peroxidation Effects 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/20—Fish extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/70—Comminuted, e.g. emulsified, fish products; Processed products therefrom such as pastes, reformed or compressed products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/02—Recovery or refining of essential oils from raw materials
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Marine Sciences & Fisheries (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Wood Science & Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fish Paste Products (AREA)
Abstract
본 발명은 광어 연육의 가수분해물의 분획물에서 분리된 펩티드를 유효성분으로 포함하는, 고혈압 치료 또는 예방용 약학 조성물 또는 식품 조성물에 관한 것으로, 광어 연육이 혈압강하 효과를 가지고, 광어 연육의 가수분해물, 상기 광어 연육의 가수분해물의 분획물과 상기 분획물에서 분리된 펩티드가 안지오텐신 I 전환 효소 (Angiotensin I converting Enzyme, ACE) 저해 활성을 가지는 것을 확인하였다. 따라서, 상기 광어 연육의 가수분해물의 분획물에서 분리된 펩티드들을 이용하여, 고혈압 치료 또는 예방용 약학 조성물 또는 식품 조성물에 사용할 수 있다. 또한, 본 발명은 광어 연육의 가수분해물과 이에서 분리된 펩티드가 라디칼 소거 효과, 산화적 스트레스에 대한 보호 효과를 가지고 ROS 생성을 억제하고, 지질 과산화 그리고 세포사멸을 억제하는 것을 확인하였다. 따라서, 상기 광어 연육의 가수분해물의 분획물에서 분리된 펩티드들을 이용하여, 항산화용 식품 조성물에 사용할 수 있다.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/609,807 US11541099B2 (en) | 2017-08-31 | 2018-08-30 | Flounder surimi having antioxidant and antihypertensive effects and method of preparing the same |
JP2019558790A JP7144441B2 (ja) | 2017-08-31 | 2018-08-30 | 抗酸化及び抗高血圧効果を有するヒラメ練肉及びその製造方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170111310A KR101921214B1 (ko) | 2017-08-31 | 2017-08-31 | 항고혈압 효과를 가지는 광어 연육 및 이의 제조방법 |
KR10-2017-0111310 | 2017-08-31 | ||
KR10-2017-0111944 | 2017-09-01 | ||
KR1020170111944A KR101918692B1 (ko) | 2017-09-01 | 2017-09-01 | 항산화 효과를 가지는 광어 연육 및 이의 제조방법 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2019045467A2 WO2019045467A2 (ko) | 2019-03-07 |
WO2019045467A3 true WO2019045467A3 (ko) | 2019-05-09 |
WO2019045467A9 WO2019045467A9 (ko) | 2019-07-11 |
Family
ID=65525795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2018/010028 WO2019045467A2 (ko) | 2017-08-31 | 2018-08-30 | 항산화 및 항고혈압 효과를 가지는 광어 연육 및 이의 제조방법 |
Country Status (3)
Country | Link |
---|---|
US (1) | US11541099B2 (ko) |
JP (1) | JP7144441B2 (ko) |
WO (1) | WO2019045467A2 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114480538A (zh) * | 2021-12-24 | 2022-05-13 | 海南三元星生物科技股份有限公司 | 一种海洋生物抗氧化活性肽组合物及其制备方法 |
CN116284341B (zh) * | 2023-02-20 | 2024-05-03 | 中国石油大学(华东) | 一种低免疫原性、降血压、抗氧化的深海鱼皮胶原蛋白肽制备及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100600578B1 (ko) * | 2004-04-12 | 2006-07-13 | 부경대학교 산학협력단 | 가자미 프레임으로부터 분리한 가수분해물 및 이를함유하는 항고혈압 조성물 |
KR100946997B1 (ko) * | 2007-11-28 | 2010-03-10 | 강원도 인제군 | 황태 가수분해물, 2차 가수분해물 또는 이로부터 분리한활성 펩티드를 유효성분으로 함유하는 조성물 |
KR101404850B1 (ko) * | 2012-10-09 | 2014-06-09 | 한국기초과학지원연구원 | 클로렐라 유래 항고혈압 활성을 갖는 펩티드 |
KR101449804B1 (ko) * | 2012-09-12 | 2014-10-13 | 부경대학교 산학협력단 | 홍어 껍질 유래 젤라틴 추출물 및 상기 추출물로부터 분리한 펩타이드를 유효성분으로 포함하는 항고혈압 조성물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10182696A (ja) * | 1996-12-27 | 1998-07-07 | Teikoku Seiyaku Co Ltd | gp120に対して親和性を有するペプチド |
JP3148153B2 (ja) * | 1997-07-03 | 2001-03-19 | 株式会社分子バイオホトニクス研究所 | 紫外線吸収検出等電点電気泳動用マーカー |
JP3271961B2 (ja) | 2000-03-27 | 2002-04-08 | 和田八蒲鉾製造株式会社 | 魚肉練り製品及びその製造方法 |
ES2375351T3 (es) * | 2002-04-01 | 2012-02-29 | Agensys, Inc. | Ácido nucleico y proteína correspondiente denominada 238p1b2 útil en el tratamiento y la detección de cáncer. |
KR101201432B1 (ko) * | 2010-08-12 | 2012-11-14 | 류홍수 | 제주산 광어를 이용하여 파우치형 광어고음 및 그의 제조방법 |
KR102017026B1 (ko) * | 2013-01-10 | 2019-09-02 | (주) 수파드엘릭사 | 염증 또는 알러지의 예방 또는 치료용 약학 조성물 및 염증 또는 알러지 개선용 화장료 조성물 |
US9951371B2 (en) * | 2014-09-17 | 2018-04-24 | Northwestern University | Probes and assays for measuring E3 ligase activity |
-
2018
- 2018-08-30 US US16/609,807 patent/US11541099B2/en active Active
- 2018-08-30 JP JP2019558790A patent/JP7144441B2/ja active Active
- 2018-08-30 WO PCT/KR2018/010028 patent/WO2019045467A2/ko active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100600578B1 (ko) * | 2004-04-12 | 2006-07-13 | 부경대학교 산학협력단 | 가자미 프레임으로부터 분리한 가수분해물 및 이를함유하는 항고혈압 조성물 |
KR100946997B1 (ko) * | 2007-11-28 | 2010-03-10 | 강원도 인제군 | 황태 가수분해물, 2차 가수분해물 또는 이로부터 분리한활성 펩티드를 유효성분으로 함유하는 조성물 |
KR101449804B1 (ko) * | 2012-09-12 | 2014-10-13 | 부경대학교 산학협력단 | 홍어 껍질 유래 젤라틴 추출물 및 상기 추출물로부터 분리한 펩타이드를 유효성분으로 포함하는 항고혈압 조성물 |
KR101404850B1 (ko) * | 2012-10-09 | 2014-06-09 | 한국기초과학지원연구원 | 클로렐라 유래 항고혈압 활성을 갖는 펩티드 |
Non-Patent Citations (1)
Title |
---|
KO, JU-YOUNG: "Small molecular preparation of flounder fish(Paralichthys olivaceus) muscle and its biological activities", MASTER`S THESIS, February 2011 (2011-02-01) * |
Also Published As
Publication number | Publication date |
---|---|
WO2019045467A2 (ko) | 2019-03-07 |
US20200179481A1 (en) | 2020-06-11 |
JP7144441B2 (ja) | 2022-09-29 |
US11541099B2 (en) | 2023-01-03 |
WO2019045467A9 (ko) | 2019-07-11 |
JP2020518572A (ja) | 2020-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20210415A (es) | Compuestos de 3-carbonilamino-5-ciclopentil-1h-pirazol que tienen actividad inhibidoria en cdk2 | |
CA3148745A1 (en) | Kras g12d inhibitors | |
MX2022015272A (es) | Inhibidores de la proteina kras g12c y usos de estos. | |
MX2022013612A (es) | Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para el tratamiento de malignidades hematologicas. | |
JOP20190281A1 (ar) | مشتق n2، n4 ثنائي فينيل بيريميدين -2، 4- ثنائي أمين، وطريقة لتحضيره، وتركيبة صيدلانية تحتوي على المشتق بوصفه مكون فعال للوقاية من السرطان أو علاجه | |
PH12016501357B1 (en) | Pharmaceutical preparation containing pyridylaminoacetic acid compound | |
WO2019045248A3 (ko) | 주름 개선 활성을 나타내는 펩타이드 및 이의 용도 | |
EP4011376A3 (en) | Combination of an alk inhibitor and an egfr inhibitor for treating cancer | |
WO2019043450A3 (en) | COSMETIC COMPOSITIONS HAVING ANTIOXIDANT PROPERTIES | |
WO2011159137A3 (ko) | 신규한 티오우레아 또는 우레아 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 aids 예방 또는 치료용 약학 조성물 | |
EP4400098A3 (en) | Co-amorphous forms of beta-lactoglobulin and a drug substance | |
WO2019045467A3 (ko) | 항산화 및 항고혈압 효과를 가지는 광어 연육 및 이의 제조방법 | |
CA3155883A1 (en) | BUCCO-DENTAL CARE COMPOSITIONS BASED ON BETA ACID OF HOPS AND AMINO ACID | |
ZA202300259B (en) | Compound for the treatment of coronaviral infections | |
EP4008718A4 (en) | HETEROARYLAMIDOPYRIDINOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM FOR THE PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASES | |
JOP20210295A1 (ar) | أشكال صلبة لمثبط GlyT1 | |
PH12021550122A1 (en) | Solubilized apyrases, methods and use | |
PH12021551070A1 (en) | Pharmaceutical composition comprising histone deacetylase 6 inhibitors | |
WO2019022482A3 (ko) | 황칠나무 추출물을 유효성분으로 포함하는 섬유화 질환의 예방 또는 치료용 조성물 | |
WO2019013495A3 (ko) | 민들레 추출물 및 레몬밤 추출물을 포함하는 간 보호용 조성물 | |
EP4005572A4 (en) | BENZAMIDE DERIVATIVE, METHOD FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITION COMPRISING IT AS AN ACTIVE SUBSTANCE FOR THE PREVENTION OR TREATMENT OF CANCER | |
MX2022005388A (es) | Compuestos de pirrolidina y piperidina. | |
EP3848039A4 (en) | PHARMACEUTICAL COMPOSITION WITH A TSP1 PROTEIN INHIBITOR AS AN ACTIVE SUBSTANCE FOR THE PREVENTION OR TREATMENT OF FABRY DISEASE | |
WO2020109233A3 (en) | Trmt2a inhibitors for use in the treatment of polyglutamine diseases | |
WO2020218727A3 (ko) | 갈색거저리 유충의 단백가수분해물로부터 분리된 펩타이드 및 이를 유효성분으로 포함하는 간 손상 예방 또는 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18851763 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2019558790 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18851763 Country of ref document: EP Kind code of ref document: A2 |